Austria vs Singapore: Number of isolates tested for ceftriaxone
Austria
245
in 2020
Singapore
232
in 2020
Austria rank
12th
Singapore rank
13th
Number of isolates tested for ceftriaxone over time
- Austria
- Singapore
How they compare
Austria currently reports 245 against 232 in Singapore, a difference of 13.
That makes Austria's figure about 1.1 times Singapore's.
The two have swapped places 3 times across 10 shared years of data; in 2009 it was Singapore ahead.
Austria ranks 12th and Singapore ranks 13th of 52 countries.
Across the 3 decades both report, Austria averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Austria | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 104 | 160 | 56 | Singapore |
| 2010s | 151.75 | 100.25 | 51.5 | Austria |
| 2020s | 245 | 232 | 13 | Austria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Austria or Singapore?
- Austria, at 245 against 232 in Singapore as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Austria and Singapore?
- 13, with Austria ahead.
- How many years of comparable data are there for Austria and Singapore?
- 10 years are reported by both, from 2009 to 2020.
- How do Austria and Singapore rank globally for number of isolates tested for ceftriaxone?
- Austria ranks 12th and Singapore ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.